| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/02/2011 | EP2289536A1 Use of bone morphogenetic proteins for healing and repair of connective tissue attachment |
| 03/02/2011 | EP2289531A2 Medicaments for increasing endogenous erythropoietine (EPO) |
| 03/02/2011 | EP2289519A2 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
| 03/02/2011 | EP2289514A1 Pramipexole once daily dosage form |
| 03/02/2011 | EP2289504A2 SIRT1 modulators for manipulating cell/organism lifespan/stress response |
| 03/02/2011 | EP2288337A1 Parenteral supplement with traceelem ntsfor treatment of i. a. sirs, burns selenium-defenciencies |
| 03/02/2011 | EP1511489B1 New pharmaceutical compositions containing flibanserin polymorph a |
| 03/02/2011 | EP1363663B1 Nucleic acid mucosal immunization |
| 03/02/2011 | EP1248613B1 Clonidine preparations |
| 03/02/2011 | EP1100824B1 Compounds with growth hormone releasing properties |
| 03/02/2011 | EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 03/02/2011 | CN101983072A Mineral absorption accelerator and iron deficiency anemia improver or food composition |
| 03/02/2011 | CN101983069A Influenza hemagglutinin and neuraminidase variants |
| 03/02/2011 | CN101983065A Agents for promoting secretion and/or suppressing decrease of adiponectin |
| 03/02/2011 | CN101983056A Preventive and/or remedy for vascular diseases |
| 03/02/2011 | CN101983055A Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 03/02/2011 | CN101185649B Levoleucovorin freeze-dried injection agent and preparation method and pharmaceutical use thereof |
| 03/02/2011 | CN101085756B Endothelin antagonist |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897732 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing |
| 03/01/2011 | US7897731 Corticotropin releasing factor 2 receptor agonists |
| 03/01/2011 | US7897729 Polymeric immunoglobulin fusion proteins that target low affinity FcγReceptors |
| 03/01/2011 | US7897644 Antiinflammatory agents; analgesics |
| 03/01/2011 | US7897628 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 03/01/2011 | US7897617 Quinuclidine derivatives and medicinal compositions containing the same |
| 03/01/2011 | US7897351 Peptides and antibodies to MUC 1 proteins |
| 03/01/2011 | US7897180 Enamel matrix protein composition for treatment of systemic inflammatory response |
| 03/01/2011 | US7897176 Hybrid composite dispersion; polycarbonateether block copolymer in aqueous solution |
| 03/01/2011 | US7897148 Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis |
| 03/01/2011 | US7897147 Treatment of premenstrual disorders |
| 03/01/2011 | CA2490878C Indole derivative and drug containing the same |
| 03/01/2011 | CA2469154C Cytotoxic protein and utilization thereof |
| 03/01/2011 | CA2468529C 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 03/01/2011 | CA2437240C Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof |
| 03/01/2011 | CA2411660C Enzyme-cleavable prodrug compounds |
| 03/01/2011 | CA2396590C 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 03/01/2011 | CA2368618C Method of enhancing the efficacy of anti-tumor agents |
| 03/01/2011 | CA2339331C Expression and export of angiogenesis inhibitors as immunofusins |
| 03/01/2011 | CA2301709C Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules |
| 02/24/2011 | WO2011021678A1 Fused heterocyclic compound |
| 02/24/2011 | WO2011021645A1 Bicyclic urea derivative or pharmacologically permitted salt thereof |
| 02/24/2011 | WO2011021597A1 Quinoline derivative-containing pharmaceutical composition |
| 02/24/2011 | WO2010104571A3 Treating chronic fatigue syndrome and prolonged qt interval |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046235 Products comprising, and uses of, decarboxylated phenolic acids derived from chlorogenic acids of coffee |
| 02/24/2011 | US20110046229 Controlled Release Drug Delivery Systems And Pharmaceutical Compositions Formed Therewith |
| 02/24/2011 | US20110046224 Methods to accelerate muscle development, decrease fat deposits, and enhance feeding efficiency in pigs |
| 02/24/2011 | US20110046221 Therapeutic intervention to mimic the effect of caloric restriction |
| 02/24/2011 | US20110046216 Stable compositions of dehydroascorbic acid |
| 02/24/2011 | US20110046206 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 02/24/2011 | US20110046205 Method for dissolving charged nucleic acid in an organic liquid |
| 02/24/2011 | US20110046190 Combinations comprising a selective cyclooxygenase-2 inhibitor |
| 02/24/2011 | US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
| 02/24/2011 | US20110046085 Oral Immunostimulation of Fish from (1-4) Linked Beta-D-Mannuronic Acid |
| 02/24/2011 | US20110046005 Method and nucleic acids for the analysis of colon cell proliferative disorders |
| 02/24/2011 | US20110045083 Use larch wood for treating inflammation |
| 02/24/2011 | US20110045067 Soft gel capsules |
| 02/24/2011 | US20110045058 Transfection reagent |
| 02/24/2011 | US20110045052 Bioactive Glass Coatings |
| 02/24/2011 | US20110045051 Extracellular matrix comprising platelet factors |
| 02/24/2011 | US20110045050 Nanoemulsion formulations for direct delivery |
| 02/24/2011 | US20110045048 Bone graft and scaffolding materials immobilized with type i collagen binding peptides |
| 02/24/2011 | US20110045044 Compositions for repair of defects in tissues, and methods of making the same |
| 02/24/2011 | US20110044973 Treatment of cystic disease with lysophosphatidic acid antagonists |
| 02/24/2011 | US20110044964 Plant-based omega chewable supplement |
| 02/24/2011 | US20110044961 Generation of Induced Pluripotent Stem Cells from Cord Blood |
| 02/24/2011 | US20110044941 Immunotherapy for reversing immune suppression |
| 02/24/2011 | US20110044921 Substances and compositions for enhancing dna repair and methods of use |
| 02/24/2011 | US20110044912 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 02/24/2011 | US20110044899 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
| 02/24/2011 | DE10251709C5 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3 |
| 02/24/2011 | CA2771403A1 Quinoline derivative-containing pharmaceutical composition |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287285A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/23/2011 | EP2287191A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287190A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287186A1 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 02/23/2011 | EP2287160A1 Novel benzothiophene oxide derivative and salt thereof |
| 02/23/2011 | EP2287147A2 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 02/23/2011 | EP2286848A2 Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis |
| 02/23/2011 | EP2286841A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/23/2011 | EP2286834A2 Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response |
| 02/23/2011 | EP2286827A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2011 | EP2286812A1 Solubilized topoisomerase poisons |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2286676A1 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves |
| 02/23/2011 | EP2286663A2 Methods and compositions for treating ectoparasite infestation |
| 02/23/2011 | EP2285778A1 Nicotinamide derivatives |
| 02/23/2011 | EP2285372A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 02/23/2011 | EP1487810B9 4-(diarylmethyl)-1-piperazinyl derivatives |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | EP1409461B1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 02/23/2011 | EP1227805B2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/23/2011 | EP1000023B1 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 02/23/2011 | CN1980664B CRTH2 receptor ligands for therapeutic use |
| 02/23/2011 | CN1882549B 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 02/23/2011 | CN101981030A Dihydro- 1H- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as S1P1 agonists |
| 02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 02/23/2011 | CN101981012A Novel tetrahydroisoquinoline derivative |